Indivior PLC (NASDAQ:INDV) Given Average Rating of “Buy” by Brokerages

Shares of Indivior PLC (NASDAQ:INDV) have received an average recommendation of “Buy” from the seven analysts that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $39.3333.

INDV has been the topic of a number of research analyst reports. Zacks Research raised Indivior from a “hold” rating to a “strong-buy” rating in a report on Monday, March 16th. Weiss Ratings lowered Indivior from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, May 6th.

Insider Transactions at Indivior

In other Indivior news, Director Stuart A. Kingsley bought 940 shares of the stock in a transaction on Friday, March 6th. The shares were purchased at an average price of $31.86 per share, with a total value of $29,948.40. Following the acquisition, the director directly owned 5,582 shares of the company’s stock, valued at $177,842.52. This represents a 20.25% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.74% of the stock is owned by company insiders.

Institutional Trading of Indivior

Several institutional investors have recently modified their holdings of INDV. CWM LLC acquired a new stake in shares of Indivior during the 3rd quarter worth approximately $25,000. Quarry LP acquired a new stake in shares of Indivior during the 3rd quarter worth approximately $26,000. Raymond James Financial Inc. acquired a new stake in shares of Indivior during the 2nd quarter worth approximately $26,000. Salomon & Ludwin LLC acquired a new stake in shares of Indivior during the 4th quarter worth approximately $30,000. Finally, Harbor Capital Advisors Inc. grew its holdings in shares of Indivior by 309.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,033 shares of the company’s stock worth $37,000 after purchasing an additional 781 shares in the last quarter. Institutional investors and hedge funds own 60.33% of the company’s stock.

Indivior Stock Up 0.2%

INDV opened at $37.53 on Monday. The firm has a market capitalization of $4.58 billion, a P/E ratio of 19.25 and a beta of 0.90. The stock’s 50 day moving average price is $33.39 and its two-hundred day moving average price is $33.72. Indivior has a 12-month low of $11.08 and a 12-month high of $41.00.

Indivior (NASDAQ:INDV) last released its earnings results on Tuesday, March 31st. The company reported $0.96 earnings per share (EPS) for the quarter. The firm had revenue of $317.00 million for the quarter. Indivior had a negative return on equity of 219.26% and a net margin of 19.44%. As a group, analysts anticipate that Indivior will post 3.35 earnings per share for the current year.

About Indivior

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.